| RS201686997 |
GRN
|
Health Risk |
Conflicting classifications of pathogenicity |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS201687037 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS201687359 |
KCNN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dehydrated hereditary stomatocytosis 2, Dehydrated hereditary stomatocytosis 2 |
| RS201687390 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Tibial muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS201687417 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Clear cell carcinoma of kidney |
| RS201688261 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS201688358 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS201688381 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS2016886160 |
NFIX
|
Health Risk |
Likely pathogenic |
— |
| RS201688627 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocytopenia 2, Inborn genetic diseases |
| RS2016886281 |
NFIX
|
Health Risk |
Conflicting classifications of pathogenicity |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS201688876 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS201689325 |
DBH
|
Health Risk |
Conflicting classifications of pathogenicity |
Orthostatic hypotension 1, Orthostatic hypotension 1 |
| RS201689565 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Difficulty walking, Spastic paraparesis |
| RS201689582 |
RTTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201689771 |
TERF2IP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201689819 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, MYO15A-related disorder |
| RS201690040 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS201690337 |
DEPDC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial focal epilepsy with variable foci, Inborn genetic diseases |
| RS201690494 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS201690610 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS201690858 |
SNORD118
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201690866 |
MAN2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of alpha-mannosidase, Intellectual disability |
| RS201691098 |
RORC
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency, Inborn genetic diseases |
| RS201691370 |
FOXH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Holoprosencephaly sequence, Inborn genetic diseases |
| RS201691420 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Duchenne muscular dystrophy |
| RS201691879 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, TG-related disorder |
| RS201691906 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2016920143 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS201692151 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS201692179 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201692212 |
MME
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2T, Charcot-Marie-Tooth disease axonal type 2T |
| RS201692248 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS201692326 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2016923973 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS201692401 |
IFT43
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 81, Cranioectodermal dysplasia 3 |
| RS201692549 |
SELENON
|
Health Risk |
Conflicting classifications of pathogenicity |
Eichsfeld type congenital muscular dystrophy, SEPN1-related disorder |
| RS201692550 |
NBEA
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS201692579 |
DCT
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 8, Oculocutaneous albinism type 8 |
| RS201692749 |
AAAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS201693154 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS201693189 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, ABCB11-related disorder |
| RS201693219 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201693280 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Conduction disorder of the heart |
| RS201693535 |
TARDBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Amyotrophic lateral sclerosis type 10 |
| RS201693690 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 28, TRIOBP-related disorder |
| RS201693851 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS201693932 |
MAP3K20
|
Health Risk |
Conflicting classifications of pathogenicity |
MAP3K20-related disorder, MAP3K20-related disorder |
| RS201694149 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS201694319 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS201694328 |
TGM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 35, TGM6-related disorder |
| RS201694466 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS201694674 |
FERMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kindler syndrome, FERMT1-related disorder |
| RS201695575 |
DNAH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201695815 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS201696115 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Congenital muscular dystrophy due to partial LAMA2 deficiency |
| RS201696514 |
SLC12A1
|
Health Risk |
Likely pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS201696710 |
JMJD1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Early myoclonic encephalopathy, Early myoclonic encephalopathy |
| RS201696973 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 diabetes mellitus, Hypophosphatemic rickets |
| RS201697063 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS201697259 |
RAB27A
|
Health Risk |
Conflicting classifications of pathogenicity |
Griscelli syndrome type 2, Autoinflammatory syndrome |
| RS201697532 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Autosomal dominant Alport syndrome |
| RS201698049 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS201698409 |
JAK3
|
Health Risk |
Conflicting classifications of pathogenicity |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, JAK3-related disorder |
| RS201698592 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Jervell and Lange-Nielsen syndrome 1 |
| RS201698934 |
ABRAXAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201699015 |
TRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Trichorhinophalangeal syndrome |
| RS201699810 |
PEX13
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 11A (Zellweger), PEX13-related disorder |
| RS201699865 |
DYNC2H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Inborn genetic diseases |
| RS201700614 |
PACS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schuurs-Hoeijmakers syndrome, Inborn genetic diseases |
| RS201700675 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS201700756 |
POLR3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukodystrophy, hypomyelinating |
| RS201701066 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS201701259 |
NHLRC2
|
Health Risk |
Pathogenic |
Fibrosis, neurodegeneration |
| RS201701647 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stargardt disease 4, Cone-rod dystrophy 12 |
| RS201701802 |
AKR1B15
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201702041 |
ROBO3
|
Health Risk |
Conflicting classifications of pathogenicity |
Gaze palsy, familial horizontal |
| RS201702563 |
RP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS201702616 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS201702907 |
PDE6C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy 4, Achromatopsia |
| RS201703193 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS201703288 |
DDB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group E |
| RS201703547 |
CTF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201703640 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS201703853 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201703858 |
ZFP57
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, transient neonatal |
| RS201703963 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, TNXB-related disorder |
| RS201704250 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS201704771 |
ACTN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 1, Focal segmental glomerulosclerosis 1 |
| RS201704801 |
SLC9A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital secretory sodium diarrhea 8, Congenital secretory sodium diarrhea 8 |
| RS201705049 |
CPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS201705066 |
LIG3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201706020 |
ALOXE3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive congenital ichthyosis 3, Autosomal recessive congenital ichthyosis 3 |
| RS201706177 |
COQ6
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial steroid-resistant nephrotic syndrome with sensorineural deafness, Inborn genetic diseases |
| RS201706408 |
SOST
|
Health Risk |
Conflicting classifications of pathogenicity |
Sclerosteosis 1, Sclerosteosis 1 |
| RS201706430 |
PCARE
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS201706459 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS201706487 |
ATG7
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia, autosomal recessive 31 |
| RS201706560 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS201706790 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |